SCHEMBL19675652

SCHEMBL19675652

Bc1ccc(NC(=O)OC(C)(C)C)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA9 Q16790 1/20 0.47
PSMB8 P28062 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP17A1 P05093 2/20 0.43
ALDH1A1 P00352 1/20 0.42
GAA P10253 1/20 0.42
HTT P42858 2/20 0.41
NAMPT P43490 1/20 0.41
MAPKAPK2 P49137 1/20 0.41
EPHX1 P07099 1/20 0.41
EPHX2 P34913 1/20 0.41
POLB P06746 2/20 0.41
NPC1 O15118 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16303890 0.86 EPHX1 (0.58) CA12CA1CA9MEN1KMT2A
SCHEMBL6490343 0.83 MEN1 (0.60) CA12CA1CA9MEN1KMT2A
SCHEMBL5425582 0.83 ALDH1A1 (0.54) CA12CA1CA9MEN1KMT2A
SCHEMBL3783697 0.83 CA12 (0.48) CA12CA1CA9PSMB8MEN1
SCHEMBL29881333 0.82 MAPT (0.56) CA12CA1CA9MEN1KMT2A
SCHEMBL6814964 0.82 MAPT (0.56) CA12CA1CA9MEN1KMT2A
SCHEMBL3202901 0.82 HTT (0.62) MEN1KMT2AALDH1A1GAAHTT
SCHEMBL4417083 0.82 CA12 (0.47) CA12CA1CA9PSMB8MEN1
SCHEMBL29666354 0.82 AR (0.49) CA12CA1CA9HTTMAPT
SCHEMBL12228592 0.82 AR (0.49) CA12CA1CA9HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3252050-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 EP disclosed
EP-3252049-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 EP disclosed